A recent study suggests that a type of drugs commonly used to treat HIV are also associated with a lower incidence of Alzheimer's disease in those who take them.
Recent research in mice investigates a new, immunotherapy-based approach to treating Alzheimer's disease aiming to clear toxic protein accumulations in the brain.
Researchers have found that immune cells in the blood of people with Alzheimer's disease present epigenetic changes, which may be a result of previous viral infections, or other factors, such as exposure to pollution.